By proceeding, you agree to our Terms of Use and Privacy Policy.
Founder and CEO of Chameleon Biosciences. Expertise includes AAV and Lenti-virus based vector production and characterization, Immunology, drug development and regulatory guidelines.
Talks About #assaydevelopment #biotechnology
Preferred Locations #Northamerica
The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field.
